S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails success in blocking Iran's unprecedented attack. G7 democracies condemn attack
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails success in blocking Iran's unprecedented attack. G7 democracies condemn attack
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails success in blocking Iran's unprecedented attack. G7 democracies condemn attack
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails success in blocking Iran's unprecedented attack. G7 democracies condemn attack
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Olympic track uniforms spark online debate about who designed them and why they're so skimpy

Sutro Biopharma (STRO) Earnings Date, Estimates & Call Transcripts

$4.14
-0.36 (-8.00%)
(As of 04/12/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

STRO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

STRO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sutro Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.95)($0.73)($0.84)
Q2 20242($0.97)($0.10)($0.54)
Q3 20242($0.99)($0.83)($0.91)
Q4 20242($1.02)($0.71)($0.87)
FY 20248($3.93)($2.37)($3.15)
Q1 20251($0.82)($0.82)($0.82)
Q2 20251($0.64)($0.64)($0.64)
Q3 20251($0.65)($0.65)($0.65)
Q4 20251($0.68)($0.68)($0.68)
FY 20254($2.79)($2.79)($2.79)

STRO Earnings Date and Information

Sutro Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Sutro Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)
------- 
11/13/2023Q3 2023($0.76)($0.81)($0.05)($0.81)$12.08 million$16.92 million
8/10/2023Q2 2023($0.73)($0.64)+$0.09($0.64)$10.45 million$10.41 million
5/15/2023Q1 2023($0.83)($0.76)+$0.07($0.67)$11.35 million$12.67 million
3/30/2023Q4 2022($0.64)($0.61)+$0.03($0.61)$11.50 million$8.63 million
11/8/2022Q3 2022($0.15)($0.37)($0.22)($0.37)$11.35 million$25.15 million
8/8/2022Q2 2022($0.74)($0.55)+$0.19($0.55)$13.64 million$28.10 million
5/9/2022Q1 2022($0.79)($0.84)($0.05)($0.84)$11.48 million$5.90 million
2/28/2022Q4 2021($0.67)($0.83)($0.16)($0.83)$10.69 million$10.65 million    
11/10/2021Q3 2021($0.65)($0.67)($0.02)($0.67)$8.85 million$8.52 million
8/8/2021Q2 2021($0.41)($0.13)+$0.28($0.13)$13.80 million$28.05 million
5/6/2021Q1 2021($0.62)($0.66)($0.04)($0.20)$6.92 million$14.66 million

Sutro Biopharma Earnings - Frequently Asked Questions

When is Sutro Biopharma's earnings date?

Sutro Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on STRO's earnings history.

How much revenue does Sutro Biopharma generate each year?

Sutro Biopharma (NASDAQ:STRO) has a recorded annual revenue of $153.73 million.

How much profit does Sutro Biopharma generate each year?

Sutro Biopharma (NASDAQ:STRO) has a recorded net income of -$106.79 million. STRO has generated -$1.78 earnings per share over the last four quarters.

What is Sutro Biopharma's EPS forecast for next year?

Sutro Biopharma's earnings are expected to grow from ($3.18) per share to ($2.96) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:STRO) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners